AU2024904192A0 - (O-acyl)-hydroxy fatty acid formulations for treatment of the eye - Google Patents

(O-acyl)-hydroxy fatty acid formulations for treatment of the eye

Info

Publication number
AU2024904192A0
AU2024904192A0 AU2024904192A AU2024904192A AU2024904192A0 AU 2024904192 A0 AU2024904192 A0 AU 2024904192A0 AU 2024904192 A AU2024904192 A AU 2024904192A AU 2024904192 A AU2024904192 A AU 2024904192A AU 2024904192 A0 AU2024904192 A0 AU 2024904192A0
Authority
AU
Australia
Prior art keywords
acyl
eye
treatment
fatty acid
hydroxy fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2024904192A
Inventor
Furqan MAULVI
Mark Willcox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NewSouth Innovations Pty Ltd
Original Assignee
NewSouth Innovations Pty Ltd
Filing date
Publication date
Application filed by NewSouth Innovations Pty Ltd filed Critical NewSouth Innovations Pty Ltd
Publication of AU2024904192A0 publication Critical patent/AU2024904192A0/en
Abandoned legal-status Critical Current

Links

AU2024904192A 2024-12-18 (O-acyl)-hydroxy fatty acid formulations for treatment of the eye Abandoned AU2024904192A0 (en)

Publications (1)

Publication Number Publication Date
AU2024904192A0 true AU2024904192A0 (en) 2025-01-09

Family

ID=

Similar Documents

Publication Publication Date Title
WO2009091538A3 (en) Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia
PT1419768E (en) Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
EP4100406A4 (en) COMPOSITIONS FOR THE TREATMENT OF OCULAR DISEASES
CA3241970A1 (en) Use of a monoester and a diester as a dielectric coolant
MY207295A (en) Method for preparing a composition comprising cetylated fatty acids
AU2025906631A0 (en) (O-acyl)-hydroxy fatty acid formulations for treatment of the eye
ZA202207542B (en) Fatty acid composition for adjuvant treatment of essential tremor and preparation method therefor
AU2025906636A0 (en) Lipid formulations for treatment of the eye
AU2024904188A0 (en) Lipid formulations for treatment of the eye
ES3065361T3 (en) Highly purified eicosapentaenoic acid, as free fatty acid for treatment of coronavirus-19 (covid-19)
AU2024900656A0 (en) Compositions and methods for the treatment of dermal disease
EP4320978A4 (en) Enhancement of message 3 for rach procedure
AU2024900544A0 (en) Composition for the treatment of skin conditions such as eczema
AU2026902517A0 (en) Compositions and methods for the treatment of oesophageal disorders
AU2025902002A0 (en) Compositions and methods for the treatment of oesophageal disorders
CA3262432A1 (en) Compositions for the treatment of cftr-mediated diseases
HK40126024A (en) Compositions for the treatment of cftr-mediated diseases
AU2025901970A0 (en) Implants for the prolonged release of active agents
AU2024901481A0 (en) Implants for the prolonged release of active agents
CA3280785A1 (en) Fatty acid compounds and methods of use
AU2024903392A0 (en) Agents for treatment of optic conditions
LT4648753T (en) Compositions for the treatment of cftr-mediated diseases
HK40117956A (en) Novel analogs of valproic acid and methods of medical treatment using the same
CA3270157A1 (en) Novel liquid oral formulations of cannabidiol
HK40128051A (en) Compositions for the treatment of disease